Skip to main content
. 2023 Jun 9;15(12):3130. doi: 10.3390/cancers15123130

Table 2.

Possible IBD drug-related malignancies.

Drug Malignancy
Thiopurines Lymphomas
Myeloproliferative syndromes
Non-melanoma skin cancers
Urinary tract cancers
Cervical carcinoma
Anti-TNF Lymphoma
Melanoma
Anti-TNF + thiopurines Lymphoma
Vedolizumab None identified
Ustekinumab None identified
JAK inhibitors Unknown
Methotrexate Non-melanoma skin cancers